Selenium in Cancer Rehabilitation-A Retrospective Study from a Specialized Clinic

被引:3
作者
Pfister, Christina [1 ]
Schoenemann, Joerg [2 ]
机构
[1] biosyn Arzneimittel GmbH, Schorndorfer Str 32, D-70734 Fellbach, Germany
[2] Inselsberg Klin Wicker GmbH & Co OHG, Fischbacher Str 36, D-99891 Bad Tabarz, Germany
关键词
selenium; zinc; micronutrient dietary intake; cancer; rehabilitation; health-related quality of life (HRQOL); QUALITY-OF-LIFE; BREAST-CANCER; BLOOD SELENIUM; SERUM-LEVELS; WHOLE-BLOOD; TISSUE; RISK; SUPPLEMENTATION; ANTIOXIDANT; POPULATION;
D O I
10.3390/nu15173827
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Micronutrient deficiencies are common at the time of cancer diagnosis and are associated with worse prognosis. Little is known about them in cancer rehabilitation. Methods: Data from routine health-related quality of life (HRQOL) were analyzed at an inpatient cancer rehabilitation center. Rehabilitation patients completed the EORTC QLQ-C30 questionnaire before and after multidisciplinary rehabilitation treatment and three months after discharge. Selenium and zinc status were measured in whole blood at these three time points. In case of selenium deficiency, up to 600 similar to g selenium per day as sodium selenite was supplemented for three weeks during and for three months after rehabilitation. Results: A total of 271 patients (breast, colon, and pancreatic cancer) were included in the analysis. There was clinically meaningful improvement in many domains of the EORTC QLQ-C30 during rehabilitation. However, the effect often waned in the three months after. Prevalence for selenium deficiency varied between 34 to 90% depending on cancer type (breast < colon < pancreas). In contrast, zinc deficiency was rare. Daily selenium supplementation of 600 similar to g was more efficient to correct selenium deficiency compared to 300 similar to g selenium per day. Rehabilitation and increasing selenium status after rehabilitation were associated with improved global quality of life, physical and emotional functioning, and fatigue. In cancer patients with decreasing selenium status, values of global quality of life, physical and emotional functioning, and fatigue were back to the values at the beginning of rehabilitation. Conclusions: Selenium deficiency is common in cancer patients admitted to a cancer rehabilitation clinic. Selenium supplementation during rehabilitation effectively corrected selenium deficiency in most cases. The positive effects of rehabilitation persisted longer when selenium status did not decrease after rehabilitation.
引用
收藏
页数:16
相关论文
共 53 条
[1]   Relatively high mortality risk in elderly Swedish subjects with low selenium status [J].
Alehagen, U. ;
Johansson, P. ;
Bjornstedt, M. ;
Rosen, A. ;
Post, C. ;
Aaseth, J. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2016, 70 (01) :91-96
[2]   Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values [J].
Amin, Suvina ;
Joo, Seongjung ;
Nolte, Sandra ;
Yoo, Hyun Kyoo ;
Patel, Nikunj ;
Byrnes, Hilary F. ;
Costa-Cabral, Sara ;
Johnson, Colin D. .
BMC CANCER, 2022, 22 (01)
[3]   Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: A population-based study [J].
Arndt, V ;
Merx, H ;
Stegmaier, C ;
Ziegler, H ;
Brenner, H .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) :4829-4836
[4]   Zinc and Breast Cancer Survival: A Prospective Cohort Study of Dietary Intake and Serum Levels [J].
Bengtsson, Ylva ;
Demircan, Kamil ;
Rosendahl, Ann H. ;
Borgquist, Signe ;
Sandsveden, Malte ;
Manjer, Jonas .
NUTRIENTS, 2022, 14 (13)
[5]   Selenium and Its Supplementation in Cardiovascular Disease-What do We Know? [J].
Benstoem, Carina ;
Goetzenich, Andreas ;
Kraemer, Sandra ;
Borosch, Sebastian ;
Manzanares, William ;
Hardy, Gil ;
Stoppe, Christian .
NUTRIENTS, 2015, 7 (05) :3094-3118
[6]   Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey [J].
Berretta, Massimiliano ;
Della Pepa, Chiara ;
Tralongo, Paolo ;
Fulvi, Alberto ;
Martellotta, Ferdinando ;
Lleshi, Arben ;
Nasti, Guglielmo ;
Fisichella, Rossella ;
Romano, Carmela ;
De Divitiis, Chiara ;
Taibi, Rosaria ;
Fiorica, Francesco ;
Di Francia, Raffaele ;
Di Mari, Anna ;
Del Pup, Lino ;
Crispo, Anna ;
De Paoli, Paolo ;
Santorelli, Adriano ;
Quagliariello, Vincenzo ;
Iaffaioli, Rosario Vincenzo ;
Tirelli, Umberto ;
Facchini, Gaetano .
ONCOTARGET, 2017, 8 (15) :24401-24414
[7]   Selenium and outcome in heart failure [J].
Bomer, Nils ;
Beverborg, Niels Grote ;
Hoes, Martijn F. ;
Streng, Koen W. ;
Vermeer, Mathilde ;
Dokter, Martin M. ;
IJmker, Jan ;
Anker, Stefan D. ;
Cleland, John G. F. ;
Hillege, Hans L. ;
Lang, Chim C. ;
Ng, Leong L. ;
Samani, Nilesh J. ;
Tromp, Jasper ;
van Veldhuisen, Dirk J. ;
Touw, Daan J. ;
Voors, Adriaan A. ;
van der Meer, Peter .
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (08) :1415-1423
[8]   Selenium Exposure and Cancer Risk: an Updated Meta-analysis and Meta-regression [J].
Cai, Xianlei ;
Wang, Chen ;
Yu, Wanqi ;
Fan, Wenjie ;
Wang, Shan ;
Shen, Ning ;
Wu, Pengcheng ;
Li, Xiuyang ;
Wang, Fudi .
SCIENTIFIC REPORTS, 2016, 6
[9]   Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA [J].
Charalabopoulos, K. ;
Kotsalos, A. ;
Batistatou, A. ;
Charalabopoulos, A. ;
Vezyraki, P. ;
Peschos, D. ;
Kalfakakou, V. ;
Evangelou, A. .
BRITISH JOURNAL OF CANCER, 2006, 95 (06) :674-676
[10]  
Charalabopoulos K, 2009, ANTICANCER RES, V29, P3465